Skip to content

Clinical study to investigate the optimal management of rheumatoid arthritis from the mortality perspective

Clinical study to investigate the optimal management of rheumatoid arthritis from the mortality perspective - Study for the optimal management of rheumatoid arthritis from the mortality perspective

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000002127
Enrollment
1500
Registered
2009-06-26
Start date
2009-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

None listed

Sponsors

Institute of Rheumatology, Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with rheumatoid arthritis treated with biologics

Exclusion criteria

Exclusion criteria: Patients who had been treated with biologics for other than rheumatoid arthritis Patients regarded as inappropriate to join the study based on medical reason or other rational reasons

Design outcomes

Primary

MeasureTime frame
mortality

Secondary

MeasureTime frame
comorbidity

Countries

Japan

Contacts

Public ContactAyako Nakajima

Tokyo Women's Medical University Institute of Rheumatology

ayakonkj@ior.twmu.ac.jp02-5269-1711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026